Skip to main content
. 2020 Feb 26;9(3):551. doi: 10.3390/cells9030551

Figure 7.

Figure 7

Chronic rofecoxib treatment reduced infarct size and did not interfere with cardioprotection by ischemic preconditioning. (* p < 0.05 vs. I/R + vehicle, # p < 0.05 vs. I/R + rofecoxib, n = 9–10).